Efficacy of new immunomodulatory drugs on major adverse cardiovascular events in patients with coronary heart disease: a systematic review and meta-analysis of randomized controlled trials
- DOI
- 10.1186/s12872-025-05250-1
- Published
- 2025-11-10
- Container
- BMC Cardiovascular Disorders
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s12872-025-05250-1,
title = {Efficacy of new immunomodulatory drugs on major adverse cardiovascular events in patients with coronary heart disease: a systematic review and meta-analysis of randomized controlled trials},
author = {Donghang He and Yuhan Li and Zefei Jiang and Xin Cao and Rong Luo},
year = {2025},
journal = {BMC Cardiovascular Disorders},
doi = {10.1186/s12872-025-05250-1},
url = {https://doi.org/10.1186/s12872-025-05250-1}
}RIS
TY - JOUR TI - Efficacy of new immunomodulatory drugs on major adverse cardiovascular events in patients with coronary heart disease: a systematic review and meta-analysis of randomized controlled trials AU - Donghang He AU - Yuhan Li AU - Zefei Jiang AU - Xin Cao AU - Rong Luo PY - 2025 JO - BMC Cardiovascular Disorders DO - 10.1186/s12872-025-05250-1 UR - https://doi.org/10.1186/s12872-025-05250-1 ER -
APA
He, D., Li, Y., Jiang, Z., Cao, X., & Luo, R. (2025). Efficacy of new immunomodulatory drugs on major adverse cardiovascular events in patients with coronary heart disease: a systematic review and meta-analysis of randomized controlled trials. BMC Cardiovascular Disorders. https://doi.org/10.1186/s12872-025-05250-1
Source records
- crossref · retrieved 2026-09-26T08:54:54.407Z